✦ LIBER ✦

Biweekly gemcitabine in two hours infusion combined with cisplatin for advanced non-small cell lung cancer (NSCLC): preliminary results of a phase II trial

✍ Scribed by I. Chacon; I. Garcia-Carbonero; L. Lopez; J. Andrade; B. Martinez; M. Cruz-Mora

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial assessing the combination

✍ Antón, A; Dı́az-Fernández, N; González Larriba, J.L; Vadell, C; Masutti, B; Mont 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 91 KB

A phase II study of a modified cisplatin

✍ Gonzalez-Martin, A; Garcia-Lopez, JL; Crespo, C; Lastra, E; Pedraza, M; Rios, A; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Gemcitabine-cisplatin (GP) vs gemcitabin

✍ P. Mazzanti; C. Massacesi; R. Mattioli; R. Trivisonne; F. Buzzi; G. De Signoribu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Gemcitabine, vinorelbine and cisplatin c

✍ E Laack; T Mende; H Dürk; M Kneba; N Dickgreber; T Welte; T Müller; J Scholtze; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Phase II trial of low-dose gemcitabine i

✍ XIONG, J; FENG, M; QIU, F; XU, J; TAO, Q; ZHANG, L; XIANG, X; ZHONG, L; YU, F; M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 188 KB

P-202 Phase II trial of tirapazamine in

✍ Reck, Martin; von Pawel, Joachim; Nimmermann, Christa; Groth, Gesine; Gatzemeier 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB